Evidence map›Paper›PMID 30740850›Full record

ArticleChembiochem : a European journal of chemical biology2019

A "Quenchergenic" Chemoselective Protein Labeling Strategy.

Partha Sarathi Addy, Yunan Zheng, James S Italia, Abhishek Chatterjee

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Partha Sarathi AddyDepartment of Chemistry, Boston College, 2609 Beacon Street, 246B Merkert Chemistry Center, Chestnut Hill, MA, 02467, USA.
Yunan ZhengDepartment of Chemistry, Boston College, 2609 Beacon Street, 246B Merkert Chemistry Center, Chestnut Hill, MA, 02467, USA.
James S ItaliaDepartment of Chemistry, Boston College, 2609 Beacon Street, 246B Merkert Chemistry Center, Chestnut Hill, MA, 02467, USA.
Abhishek ChatterjeeDepartment of Chemistry, Boston College, 2609 Beacon Street, 246B Merkert Chemistry Center, Chestnut Hill, MA, 02467, USA.ORCID 0000-0002-6231-5302

Funding

A novel approach to define the roles of oxidative and nitrative post-trasnlational modifications of tryptophan in human biologyR01GM124319 · NIGMS · BOSTON COLLEGE · PI CHATTERJEE, ABHISHEK · 2017 to 2019
$916k
A novel strategy to capture post-translational modification-triggered protein-protein interactionsR01GM126220 · NIGMS · BOSTON COLLEGE · PI CHATTERJEE, ABHISHEK · 2018 to 2019
$589k
NIGMS NIH HHS R01 GM124319NIGMS NIH HHS R01 GM126220
6 · The paper itself

Abstract

Dynamic changes in protein structure can be monitored by using a fluorescent probe and a dark quencher. This approach is contingent upon the ability to precisely introduce a fluorophore/quencher pair into two specific sites of a protein of interest. Despite recent advances, there is continued demand for new and convenient approaches to site-selectively label proteins with such optical probes. We have recently developed a chemoselectively rapid azo-coupling reaction (CRACR) for site-specific protein labeling; it relies on rapid coupling between a genetically encoded 5-hydroxytryptophan residue and various aromatic diazonium ions. Herein, it is reported that the product of this conjugation reaction, a highly chromophoric biarylazo group, is a potent fluorescence quencher. The absorption properties of this azo product can be tuned by systematically altering the structure of the aryldiazonium species. A particular "quenchergenic" aryldiazonium has been identified that, upon conjugation, efficiently quenches the fluorescence of green fluorescent protein, which is a widely used genetically encoded fluorescent probe that can be terminally attached to target proteins. This fluorophore/quencher pair was used to evaluate the protein-labeling kinetics of CRACR, as well as to monitor the proteolysis of a fusion protein.

Indexed as

5-HydroxytryptophanAzo CompoundsColoring AgentsGreen Fluorescent ProteinsMolecular ProbesMutationProtein DomainsProtein EngineeringProteolysisRecombinant Fusion ProteinsSmall Ubiquitin-Related Modifier Proteins5-HydroxytryptophanAzo CompoundsColoring AgentsGreen Fluorescent ProteinsMolecular ProbesRecombinant Fusion ProteinsSmall Ubiquitin-Related Modifier ProteinschemoselectivityFRETgenetic code expansionprotein modificationsproteolysisunnatural amino acids

Identifiers

PMID30740850
PMCPMC6663590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.